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Introduction: Immunohistochemistry helps to realize a differential diagnosis of
intraductal proliferative lesions of the breast. Biomarkers provide data about the grade
of differentiation and size of the lesion, which are necessary to predict the risk of
malignancy. Purpose: Immunohistochemical research of normal and hyperplastic
ductal breast epithelium and the evaluation of histological subtypes according to the
expression of the markers. Keywords: immunohistochemistry, ductal breast
epithelium, hyperplasia.
Material and methods: In the study were included following immunohistochemical markers: CK5/6, CK7/8,
34ᵦE12, p63, E-cadherin, SMA, Ki67, ER, PR, Her2/neu. A rigorous analysis of markers expression has been realized
according to DIN (ductal intraepithelial neoplasia) classification, as well has been performed the molecular profile of
tumors and differential diagnosis with ductal carcinoma in situ.
Results: The ductal and lobular units are consisted of luminal and basal epithelial cells. Luminal cells express CK7/8,
CK18/19. The basal compartment contains cells which are immunostained by CK5, CK7, CK14, CK17. UDH (usual ductal
hyperplasia) expresses CK5, CK5/6, 34ᵦE12. ADH (atypical ductal hyperplasia) is positive for E-cadherin. In flat epitelial
atypia (FEA) the cells are immunostained by CK19, ER, PR. In 75%, DCIS (ductal carcinoma in situ) is positive for ER, PR, E-
cadherin. The 34ᵦE12 receptor is expressed in 90% of UDH. The expression of CK5/6 occurs in 96% of ADH and DCIS. The
expression of Her2/neu marker reaches 80% in DCIS high grade and has low expression in DCIS low grade.
Conclusions: The application of immunohistochemical markers aids the assessment of morphological diagnosis
of breast epithelium hyperplasia. Cytokeratins are superior to others in the establishment of cellular source of
proliferative lesion and provide an efficient differential diagnosis with malignancies.
Traditional terminology DIN terminology
UDH ( usual ductal hyperplasia ) UDH ( usual ductal hyperplasia )
FEA ( Flat epithelial atypia ) DIN 1A
(ductal intraepithelial neoplasia, grade 1A )
ADH ( Atypical ductal hyperplasia ) DIN 1B
(ductal intraepithelial neoplasia, grade 1B )
DCIS grade 1 ( ductal carcinoma in situ, low
grade )
DIN 1C
(ductal intraepithelial neoplasia, grade 1C )
DCIS grade 2 ( ductal carcinoma in situ,
intermediate grade )
DIN 2
(ductal intraepithelial neoplasia, grade 2 )
DCIS grade 3 ( ductal carcinoma in situ,
high grade )
DIN 3
(ductal intraepithelial neoplasia, grade 3 )
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